Novo Nordisk to Establish New Production Facility in Denmark with $1.2 Billion Investment 16 December 2024: Novo Nordisk, a leading global healthcare company has unveiled plans to invest $1.2 bn in the construction of a brand-new production facility in Odense, Denmark. This
#LBS25 to Spotlight Advancements in Pharmaceutical Biotechnology, Digital Health, Medical Devices, Advanced Therapies, and More London, December 10: The second edition of the London Biotechnology Show (#LBS) continues to elevate its prestige with each passing day, as more renowned speakers and leading exhibitors join the
Interview with Behzad Mahdavi, Executive Chairman at OpenCell Technologies: Insights on Gene Therapies, Challenges and Solutions Gene therapy offers groundbreaking possibilities for treating genetic disorders, yet its journey to mainstream clinical use is hindered by key obstacles, involving safety, efficacy, delivery, and high manufacturing costs. In
From Discovery Park to Merck, Major Industry Players to Showcase at London Biotechnology Show 2025 London, November 4: Back for its second year, the London Biotechnology Show (#LBS25) gathers prominent biotech leaders, policymakers, and industry enthusiasts for an unparalleled showcase. Attendees can look forward to
UK Biotech Sector Achieves Impressive £808 Million in Q3 Funding October 21, 2024: The UK biotech sector achieved an impressive £808 million in funding during Q3 2024, successfully navigating challenging global market conditions and showcasing sustained investor confidence. This information
UK’s Life Science Sector Receives £279 Million Boost to Combat Health Issues October 14, 2024: The UK's leading life sciences sector is set to receive a £279 million boost to address major health challenges, as Lilly, the world's
IMU Biosciences Joins Innovative UK Research Consortium on Cancer Immunotherapy Responses October 07, 2024: IMU Biosciences, a biotechnology company at the forefront of systems-level immune profiling using AI to advance precision medicine, has announced its involvement in MANIFEST (Multiomic ANalysis of
Interview with Deon Neveling, CEO and Co-founder of Probipher Probiotics, long recognized for their health benefits in humans, are increasingly gaining attention for their potential to improve animal health and boost growth. In a recent interview, Deon Neveling, CEO
World’s First Ovarian Cancer Vaccine Being Developed in the UK October 4, 2024: The University of Oxford, recognised for its contributions to medical science, has secured funding up to £600,000 over the next three years from Cancer Research UK
Cytiva and Pear Bio Enhance Cancer Medicine Personalization with Innovative Single-Cell Approaches September 25, 2024: Cytiva, a global leader in life sciences and bioprocessing, and Pear Bio, company specialising in single-cell analysis technologies, have joined forces to advance personalised cancer treatment through
First-Ever Human Procedure for Graphene-Based Brain-Computer Interface Introduced by INBRAIN Neuroelectronics September 28, 2024: INBRAIN Neuroelectronics is a brain-computer interface therapeutics (BCI-Tx) specialising in graphene-based technologies, has announced the successful completion of the world’s first human procedure of its cortical
Neuralink’s New Blindsight Technology Receives FDA Approval September 20, 2024: Musk's brain-computer interface company, Neuralink, has announced that its latest innovation, Blindsight, has received licensing from the U.S. Food and Drug Administration (FDA). This
Exclusive Interview with Lore Gruenbaum, VP of Research for The Leukemia & Lymphoma Society's Therapy Acceleration Program Blood cancer continues to be a devastating disease, requiring ongoing research and support to advance treatments and improve access to care. Philanthropy plays a key role in driving innovation and
Insightful Session with Mathew Cook, Senior Director of Sales for the UK, Ireland, and Nordics at Merck Life Science In a recent interview, Mathew Cook, Senior Director Sales - UK, Ireland Nordics (Academia, Public & Pharma) at Merck Life Science | CSAM, talked with Muhammad Younis about the evolving landscape
Stem Cell Discovery Set to Revolutionise Bone Marrow Transplants September 2, 2024: Researchers at the Murdoch Children’s Research Institute in Melbourne and the University of Birmingham have achieved a major breakthrough in blood stem cell engineering. This innovative
